George C Cyriac

Title: George C Cyriac: Innovator in Dopamine D3 Receptor Research.

Introduction

George C Cyriac is a notable inventor based in the United States. He has made significant contributions to the field of pharmacology, particularly in the development of dopamine D3 receptor selective ligands. His work focuses on creating compounds that can modulate the effects of substances like cocaine, which are known to have addictive properties.

Latest Patents

One of his key patents is titled "4-Phenylpiperazine Derivatives With Functionalized Linkers As Dopamine D3 Receptor Selective Ligands And Methods Of Use." This patent describes the development of dopamine D3 receptor antagonists and partial agonists that can influence the reinforcing and drug-seeking behaviors associated with cocaine and other abused substances. By introducing functional groups into the butylamide linking chain of the 4-phenylpiperazine class of ligands, Cyriac has achieved improved D3 receptor affinity, selectivity, and water solubility. The modifications he has made are generally well tolerated at D3 receptors, achieving high selectivity over D2 and D4 receptors.

Career Highlights

Throughout his career, George C Cyriac has focused on innovative approaches to drug design and development. His research has contributed to a better understanding of how specific receptor interactions can lead to therapeutic advancements in treating addiction and related disorders.

Collaborations

Cyriac has collaborated with notable colleagues in his field, including Amy Hauck Newman and Peter Grundt. These partnerships have enhanced the scope and impact of his research, leading to advancements in the understanding of dopamine receptor interactions.

Conclusion

George C Cyriac is a prominent figure in the field of pharmacology, with a focus on dopamine D3 receptor research. His innovative work has the potential to influence future treatments for addiction and improve therapeutic outcomes.